CD4 and neoplasm: Increased tumor-derived NeuGcGM3 ganglioside in sentinel lymph nodes have been suggested to directly influence coordinated interactions between DC and both helper and regulatory CD4+ T cells abrogating an anti-tumor-specific immune response [41].